MedTrace Logo

Serum Thyroglobulin as a Marker of Iodine Status During Pregnancy

NCT02927119 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 189

Last updated 2016-10-06

No results posted yet for this study

Summary

The purpose of the investigation is to assess iodine status of pregnant women at week 16 of gestation targeting serum thyroglobulin as a biomarker of iodine deficiency. The investigators aim to assess whether pre-gestational initiation of iodine supplementation is more advantageous in comparison to supplementation start at the time of pregnancy detection.

Conditions

  • Dietary Iodine Deficiency
  • Thyroid; Functional Disturbance

Interventions

DIETARY_SUPPLEMENT

iodine

≥ 150 µg/day iodine supplementation (iodine containing pregnancy supplement) prior to enrollment

Sponsors & Collaborators

  • University of Debrecen

    lead OTHER

Principal Investigators

  • Endre V Nagy, MD, PhD, DSc · University of Debrecen

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2014-12-31
Completion
2014-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02927119 on ClinicalTrials.gov